Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxiracetam in Vascular Cognitive Impairment (OVeRCO ME)
KCT0005137Phase 4Recruiting
- Sponsor
- Korean Drug
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Oxiracetam in vascular cognitive disorder (VCD), sponsored by Korean Drug. Started Jan 2018; status: recruiting.
02
Drugs
Oxiracetam
03
Conditions
vascular cognitive disorder (VCD)
Beyond the preview
Go deeper on KCT0005137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005137.